Metabolism of the hamster pancreatic carcinogen methyl-2- oxopropylnitrosamine by hamster liver and pancreas

Sheng C. Chen, Xiaojie Wang, Lin Zhou, Carol Kolar, Terence A. Lawson, Sidney S. Mirvish

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background. The mechanism whereby methyl-2-oxopropylnitrosamine (MOP) is activated remains unknown. To begin investigating this mechanism, we followed MOP disappearance during its incubation with liver and pancreatic slices and homogenates from Syrian hamsters and rats. Methods. After the incubations, disappearance of 100 μM MOP and appearance of a metabolite was followed by high-performance liquid chromatography (HPLC) with ultraviolet (UV) detection. Results. Disappearance rates were 1.2 nmol/mg protein/h for hamster liver slices; zero for hamster pancreatic slices, ducts and acini; zero for rat liver and pancreatic slices; and 11.8, 12.8, 1.3, and 2.3 nmol MOP/mg/h for hamster liver homogenate and cytosol, and hamster pancreas homogenate and microsomes, respectively. The principal MOP metabolite was identified as methyl-2-hydroxypropylnitrosamine (MHP) by its HPLC behavior and its 1H-NMR and mass spectra. MHP yields were generally similar to MOP consumption, but were zero for hamster pancreatic homogenate despite its ability to metabolize MOP. Conclusion. MOP is a pancreatic carcinogen in hamsters but not in rats. In metabolic studies, hamster liver slices and homogenate (especially the cytosol) produced MHP from MOP. This is probably an inactivation reaction. Hamster pancreas homogenate (especially the microsome fraction), but not rat pancreas homogenate, metabolized MOP without forming MHP, indicating another route of metabolism, perhaps activation to give the proximal carcinogen.

Original languageEnglish (US)
Pages (from-to)105-112
Number of pages8
JournalInternational Journal of Pancreatology
Volume27
Issue number2
StatePublished - Jun 26 2000

Fingerprint

Cricetinae
Carcinogens
Pancreas
Liver
Microsomes
Cytosol
High Pressure Liquid Chromatography
methyl-2-oxopropylnitrosamine
Aptitude
Pancreatic Ducts
Mesocricetus
methyl-2-hydroxypropylnitrosamine

Keywords

  • Hamster pancreas
  • Ketone reduction
  • Metal-working fluids
  • Methyl-2-hydroxypropylnitrosamine
  • Methyl-2-oxopropylnitrosamine
  • Pancreatic carcinogenesis

ASJC Scopus subject areas

  • Oncology
  • Endocrinology
  • Gastroenterology

Cite this

Chen, S. C., Wang, X., Zhou, L., Kolar, C., Lawson, T. A., & Mirvish, S. S. (2000). Metabolism of the hamster pancreatic carcinogen methyl-2- oxopropylnitrosamine by hamster liver and pancreas. International Journal of Pancreatology, 27(2), 105-112.

Metabolism of the hamster pancreatic carcinogen methyl-2- oxopropylnitrosamine by hamster liver and pancreas. / Chen, Sheng C.; Wang, Xiaojie; Zhou, Lin; Kolar, Carol; Lawson, Terence A.; Mirvish, Sidney S.

In: International Journal of Pancreatology, Vol. 27, No. 2, 26.06.2000, p. 105-112.

Research output: Contribution to journalArticle

Chen, SC, Wang, X, Zhou, L, Kolar, C, Lawson, TA & Mirvish, SS 2000, 'Metabolism of the hamster pancreatic carcinogen methyl-2- oxopropylnitrosamine by hamster liver and pancreas', International Journal of Pancreatology, vol. 27, no. 2, pp. 105-112.
Chen, Sheng C. ; Wang, Xiaojie ; Zhou, Lin ; Kolar, Carol ; Lawson, Terence A. ; Mirvish, Sidney S. / Metabolism of the hamster pancreatic carcinogen methyl-2- oxopropylnitrosamine by hamster liver and pancreas. In: International Journal of Pancreatology. 2000 ; Vol. 27, No. 2. pp. 105-112.
@article{f4f6e12d809c4d38a262ea329b772ae9,
title = "Metabolism of the hamster pancreatic carcinogen methyl-2- oxopropylnitrosamine by hamster liver and pancreas",
abstract = "Background. The mechanism whereby methyl-2-oxopropylnitrosamine (MOP) is activated remains unknown. To begin investigating this mechanism, we followed MOP disappearance during its incubation with liver and pancreatic slices and homogenates from Syrian hamsters and rats. Methods. After the incubations, disappearance of 100 μM MOP and appearance of a metabolite was followed by high-performance liquid chromatography (HPLC) with ultraviolet (UV) detection. Results. Disappearance rates were 1.2 nmol/mg protein/h for hamster liver slices; zero for hamster pancreatic slices, ducts and acini; zero for rat liver and pancreatic slices; and 11.8, 12.8, 1.3, and 2.3 nmol MOP/mg/h for hamster liver homogenate and cytosol, and hamster pancreas homogenate and microsomes, respectively. The principal MOP metabolite was identified as methyl-2-hydroxypropylnitrosamine (MHP) by its HPLC behavior and its 1H-NMR and mass spectra. MHP yields were generally similar to MOP consumption, but were zero for hamster pancreatic homogenate despite its ability to metabolize MOP. Conclusion. MOP is a pancreatic carcinogen in hamsters but not in rats. In metabolic studies, hamster liver slices and homogenate (especially the cytosol) produced MHP from MOP. This is probably an inactivation reaction. Hamster pancreas homogenate (especially the microsome fraction), but not rat pancreas homogenate, metabolized MOP without forming MHP, indicating another route of metabolism, perhaps activation to give the proximal carcinogen.",
keywords = "Hamster pancreas, Ketone reduction, Metal-working fluids, Methyl-2-hydroxypropylnitrosamine, Methyl-2-oxopropylnitrosamine, Pancreatic carcinogenesis",
author = "Chen, {Sheng C.} and Xiaojie Wang and Lin Zhou and Carol Kolar and Lawson, {Terence A.} and Mirvish, {Sidney S.}",
year = "2000",
month = "6",
day = "26",
language = "English (US)",
volume = "27",
pages = "105--112",
journal = "Journal of Gastrointestinal Cancer",
issn = "1941-6628",
publisher = "Humana Press",
number = "2",

}

TY - JOUR

T1 - Metabolism of the hamster pancreatic carcinogen methyl-2- oxopropylnitrosamine by hamster liver and pancreas

AU - Chen, Sheng C.

AU - Wang, Xiaojie

AU - Zhou, Lin

AU - Kolar, Carol

AU - Lawson, Terence A.

AU - Mirvish, Sidney S.

PY - 2000/6/26

Y1 - 2000/6/26

N2 - Background. The mechanism whereby methyl-2-oxopropylnitrosamine (MOP) is activated remains unknown. To begin investigating this mechanism, we followed MOP disappearance during its incubation with liver and pancreatic slices and homogenates from Syrian hamsters and rats. Methods. After the incubations, disappearance of 100 μM MOP and appearance of a metabolite was followed by high-performance liquid chromatography (HPLC) with ultraviolet (UV) detection. Results. Disappearance rates were 1.2 nmol/mg protein/h for hamster liver slices; zero for hamster pancreatic slices, ducts and acini; zero for rat liver and pancreatic slices; and 11.8, 12.8, 1.3, and 2.3 nmol MOP/mg/h for hamster liver homogenate and cytosol, and hamster pancreas homogenate and microsomes, respectively. The principal MOP metabolite was identified as methyl-2-hydroxypropylnitrosamine (MHP) by its HPLC behavior and its 1H-NMR and mass spectra. MHP yields were generally similar to MOP consumption, but were zero for hamster pancreatic homogenate despite its ability to metabolize MOP. Conclusion. MOP is a pancreatic carcinogen in hamsters but not in rats. In metabolic studies, hamster liver slices and homogenate (especially the cytosol) produced MHP from MOP. This is probably an inactivation reaction. Hamster pancreas homogenate (especially the microsome fraction), but not rat pancreas homogenate, metabolized MOP without forming MHP, indicating another route of metabolism, perhaps activation to give the proximal carcinogen.

AB - Background. The mechanism whereby methyl-2-oxopropylnitrosamine (MOP) is activated remains unknown. To begin investigating this mechanism, we followed MOP disappearance during its incubation with liver and pancreatic slices and homogenates from Syrian hamsters and rats. Methods. After the incubations, disappearance of 100 μM MOP and appearance of a metabolite was followed by high-performance liquid chromatography (HPLC) with ultraviolet (UV) detection. Results. Disappearance rates were 1.2 nmol/mg protein/h for hamster liver slices; zero for hamster pancreatic slices, ducts and acini; zero for rat liver and pancreatic slices; and 11.8, 12.8, 1.3, and 2.3 nmol MOP/mg/h for hamster liver homogenate and cytosol, and hamster pancreas homogenate and microsomes, respectively. The principal MOP metabolite was identified as methyl-2-hydroxypropylnitrosamine (MHP) by its HPLC behavior and its 1H-NMR and mass spectra. MHP yields were generally similar to MOP consumption, but were zero for hamster pancreatic homogenate despite its ability to metabolize MOP. Conclusion. MOP is a pancreatic carcinogen in hamsters but not in rats. In metabolic studies, hamster liver slices and homogenate (especially the cytosol) produced MHP from MOP. This is probably an inactivation reaction. Hamster pancreas homogenate (especially the microsome fraction), but not rat pancreas homogenate, metabolized MOP without forming MHP, indicating another route of metabolism, perhaps activation to give the proximal carcinogen.

KW - Hamster pancreas

KW - Ketone reduction

KW - Metal-working fluids

KW - Methyl-2-hydroxypropylnitrosamine

KW - Methyl-2-oxopropylnitrosamine

KW - Pancreatic carcinogenesis

UR - http://www.scopus.com/inward/record.url?scp=0034080195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034080195&partnerID=8YFLogxK

M3 - Article

C2 - 10862509

AN - SCOPUS:0034080195

VL - 27

SP - 105

EP - 112

JO - Journal of Gastrointestinal Cancer

JF - Journal of Gastrointestinal Cancer

SN - 1941-6628

IS - 2

ER -